It has been
reported that cordycepin is intracellularly converted into its
5-mono-, di- and triphosphates that inhibit the activity of ribose-phosphate pyrophosphokinase and 5-phosphoribosyl-1-
pyrophosphate amidotransferase in the de novo biosynthesis of
purines